leadf
logo-loader
ASX:PXS

Pharmaxis Ltd

Receive alerts
Market:
ASX
Market Cap:
$32.06 m
Price
0.08 AUD
Change
-4.71%
52 weeks high
0.29
52 weeks low
0.05

In brief

Pharmaxis Ltd (ASX:PXS) is a specialty pharmaceutical company focused on the development of new products for the diagnosis and treatment of chronic respiratory and immune disorders.

Snapshot

The company completed both its phase 1b trial of its systemic pan‐LOX inhibitor and a further phase 1 dosing study of its LOXL2 inhibitor in March.